- Tytuł:
- Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet Infectious Diseases September 2021 21(9):1271-1281
Czasopismo naukowe